FR2092105A1 - - Google Patents

Info

Publication number
FR2092105A1
FR2092105A1 FR7115153A FR7115153A FR2092105A1 FR 2092105 A1 FR2092105 A1 FR 2092105A1 FR 7115153 A FR7115153 A FR 7115153A FR 7115153 A FR7115153 A FR 7115153A FR 2092105 A1 FR2092105 A1 FR 2092105A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7115153A
Other versions
FR2092105B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of FR2092105A1 publication Critical patent/FR2092105A1/fr
Application granted granted Critical
Publication of FR2092105B1 publication Critical patent/FR2092105B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8142Aspartate protease (E.C. 3.4.23) inhibitors, e.g. HIV protease inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
FR7115153A 1970-04-28 1971-04-28 Expired FR2092105B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP45035900A JPS5022116B1 (fr) 1970-04-28 1970-04-28

Publications (2)

Publication Number Publication Date
FR2092105A1 true FR2092105A1 (fr) 1972-01-21
FR2092105B1 FR2092105B1 (fr) 1974-10-18

Family

ID=12454886

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7115153A Expired FR2092105B1 (fr) 1970-04-28 1971-04-28

Country Status (8)

Country Link
US (1) US3878185A (fr)
JP (1) JPS5022116B1 (fr)
CA (1) CA983419A (fr)
CH (1) CH551487A (fr)
DE (1) DE2120930C3 (fr)
FR (1) FR2092105B1 (fr)
GB (1) GB1309524A (fr)
ZA (1) ZA712735B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2182940A1 (fr) * 1972-04-07 1973-12-14 Takeda Chemical Industries Ltd

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971736A (en) * 1975-01-21 1976-07-27 Merck & Co., Inc. Cathepsin in D inhibitors
US3973006A (en) * 1975-02-21 1976-08-03 E. R. Squibb & Sons, Inc. Peptide enzyme inhibitors of angiotensin I
US4206283A (en) 1975-09-12 1980-06-03 Sumitomo Chemical Company, Limited Protease inhibitors
US4126606A (en) * 1976-10-04 1978-11-21 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Physiologically active peptides and a process for preparation thereof
US4167448A (en) * 1976-10-04 1979-09-11 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Process for preparation of physiologically active peptides
FR2399409A1 (fr) * 1977-08-04 1979-03-02 Anvar Nouveaux derives de la pepstatine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2531951A1 (fr) * 1982-08-17 1984-02-24 Sanofi Sa Derives peptidiques inhibiteurs de proteases acides, procede pour leur preparation et medicaments qui en contiennent
US6448060B1 (en) * 2000-03-31 2002-09-10 Council Of Scientific And Industrial Research Alkalothermophilic bacillus that produces a protease inhibitor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2052964A1 (fr) * 1969-06-13 1971-04-16 Microbial Chem Res Found

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268212A (en) * 1968-04-19 1972-03-22 Zaidan Hojin Biseibutsu Tripeptide derivatives
US3840516A (en) * 1969-06-13 1974-10-08 Microbial Chem Res Found Biologically active substance,pepstatin and production processes thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2052964A1 (fr) * 1969-06-13 1971-04-16 Microbial Chem Res Found

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2182940A1 (fr) * 1972-04-07 1973-12-14 Takeda Chemical Industries Ltd

Also Published As

Publication number Publication date
FR2092105B1 (fr) 1974-10-18
DE2120930B2 (de) 1974-04-18
US3878185A (en) 1975-04-15
GB1309524A (en) 1973-03-14
DE2120930A1 (de) 1971-11-18
DE2120930C3 (de) 1974-11-21
CH551487A (de) 1974-07-15
ZA712735B (en) 1972-01-26
CA983419A (en) 1976-02-10
JPS5022116B1 (fr) 1975-07-28

Similar Documents

Publication Publication Date Title
FR2092105B1 (fr)
AU1473870A (fr)
AU2044470A (fr)
AU1336970A (fr)
AU1833270A (fr)
AU2396070A (fr)
AU1326870A (fr)
AU2085370A (fr)
AU1517670A (fr)
AU2017870A (fr)
AU1716970A (fr)
AU2130570A (fr)
AU1943370A (fr)
AU2130770A (fr)
AU1832970A (fr)
AU2119370A (fr)
AU1872870A (fr)
AU1343870A (fr)
AU1789870A (fr)
AU1879170A (fr)
AU1689770A (fr)
AU1603270A (fr)
AU1881070A (fr)
AU1841070A (fr)
AU1591370A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse